Morgan Stanley, Leerink, Stifel and Cantor Fitzgerald acted as joint book running managers for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRVI:
- Promising Phase 2b Results for Haduvio in IPF-CC Drive Buy Rating and Highlight Market Potential
- Buy Rating for Trevi Therapeutics: Promising Phase 2b Results for Haduvio in IPF-CC
- Closing Bell Movers: Credo Technology jumps 11% on earnings
- Trevi Therapeutics Terminates ATM Prospectus with Leerink
- Trevi Therapeutics price target raised to $23 from $20 at Oppenheimer
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue